Colgate-Palmolive’s Organic Growth Rate Didn’t Change At All
Everything Inside It Did.
Q2 2026: organic sales grew 2.4%, exactly matching Q2 2025. Net pricing fell from 3.2% to 1.6%. Organic volume rose from -0.2% to +0.8%. Same headline number, different company underneath it.
Colgate-Palmolive’s organic sales grew 2.4% in Q2 2026. They also grew 2.4% in Q2 2025.
That is not a typo, and it is not a coincidence worth skipping past. The identical number is hiding the most useful story in this result. What changed is everything sitting underneath it.
The Number That Didn’t Move, and the Number Underneath It
Net pricing contributed 1.6 percentage points to that 2.4% figure this quarter. A year ago, pricing contributed 3.2 points. Organic volume moved the other way. It was -0.2% in Q2 2025. It is +0.8% now, the third consecutive quarter of sequential global volume improvement.
Run the exchange rate. Colgate gave back roughly 1.6 points of price growth to buy back roughly 1.0 point of volume growth. Call this the volume handback: a company deliberately trading pricing power it built during the inflationary years for the volume it lost in the process. The trade is not free. It is also not obviously a good deal at face value, since price fell further than volume rose. What it buys is a growth mix that survives a slowdown in pricing power far better than a mix built entirely on price would.
Reported net sales reached $5,361 million, up 4.9% from $5,110 million a year earlier. Look at what is actually inside that 4.9%. Foreign exchange contributed 2.4 points, a full swing from a currency headwind a year ago. Roughly half of the headline growth number is currency, not commercial performance. Reported volume came in at 0.9%, helped by a 0.1 point contribution from the Prime100 acquisition. Organic sales growth itself included a planned 0.4-point drag from exiting low-margin private-label pet food manufacturing.
